PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
60.42
ESG score 80-90% of EXEL's 68.74. Walter Schloss would scrutinize governance quality and regulatory exposure.
57.61
Environmental score 80-90% of EXEL's 67.30. Walter Schloss would scrutinize carbon exposure and transition planning.
61.21
Social score 80-90% of EXEL's 70.02. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
62.44
Governance score 90-95% of EXEL's 68.89. Bill Ackman would demand clear governance improvement catalysts.